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Aim 
To evaluate the impact of a Diabetes Specialist Nurse prescriber on insulin and oral 
hypoglycaemic agent medication errors and length of stay. 
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Background 
The National Health Service has committed to a 40% reduction in the number of drug 
errors in the use of prescribed medicines. Drug errors in diabetes care are a common 
cause of significant morbidity and complications. Nurse prescribing creates an 
opportunity for nurses to improve care for these patients.  
 
Design 
A quasi-experiment using six wards in a single hospital trust. 
 
Methods  
In-patient care of a convenience sample of patients with diabetes was evaluated before 
(n=27) and after (n=29) the intervention of a Diabetes Specialist Nurse prescriber. 
Prospective data was collected to measure insulin and oral hypoglycaemic medication 
errors and length of stay.  
 
Results 
There was a significant reduction in the total number of errors between the pre-
intervention and intervention group (mean reduction 21 errors) (p=0.016). The median 
length of stay was reduced by three days. The total number of errors and length of 
stay were affected by admission category (p=0.0004).  
 
Conclusions 
A medicines management intervention, provided by a Diabetes Specialist Nurse 
prescriber, had a positive effect on the system of delivering medicines to patients with 
diabetes, and significantly reduced the number of errors. This reduction had some 
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effect on length of stay. The cost saving was sufficient to finance a Diabetes Specialist 
Nurse prescriber post.  
 
 
Relevance to Clinical Practice  
 Errors frequently occur in the prescription and administration of medicines to 
patients with diabetes 
 The education of healthcare professionals is a factor contributing to these errors. 
 Nurse prescribing provides a new system by which to educate patients and staff 
about their medicines.  
 A  Diabetes Specialist Nurse prescriber can reduce insulin and oral hypoglycaemic 
agent medication errors. This reduction had some effect on length of stay. 
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 INTRODUCTION  
Since 1997 a  large number of radical reforms have been introduced within the 
National Health Service (NHS)  in an attempt to control cost and improve quality  
(Department of Health (DoH) 1998, DoH 2000). Such reforms have increasingly 
become an essential requirement of service delivery. In NHS organisations in the 
United Kingdom (UK) the incidence of medication error (ME) is one specific 
indicator of quality that has been adopted to demonstrate medication safety (DoH 
2004). Although, the majority of MEs do not result in harm to the patient, it is 
suggested that the direct costs of medication errors in the NHS hospitals are £200-400 
million per year (DoH 2004). It is evident from the literature that patients who suffer 
adverse events and/or medication errors also experience an increased length of stay 
(LOS) of between 2-8 days (Wilson et al. 1995, Classen et al. 1997, Vincent et al. 
2001).  
 
The National Patient Safety Agency recently adopted the following definition of 
medication error (DoH 2004 P20):  
 
medication error is any preventable event that may cause or lead to inappropriate 
medication use or patient harm while the medication is in the control of health 
professional, patient or consumer. 
 
Patients with diabetes occupy approximately 10% of hospital in-patient beds and are 
likely to be admitted to hospital twice as often and stay twice as long as people 
without diabetes (Currie et al. 1997). Errors in diabetes care, which patients 
experience during admission to hospital, are also a common cause of significant 
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morbidity and complications (Hellman 2001). A lack of information, inappropriate 
amounts and timings of meals, unnecessary side effects from medicines,  delayed 
hospital discharge and prolonged admission as a result of errors in the medication 
process, are all identified shortfalls at a national level  in the diabetes service (Hiscock 
et al. 2001, van der Bijl & Shortridge-Baggett 2001, Fan et al. 2005). 
 
A quarter of people living with this disease also experience three or more other long-
term conditions (DoH 2003a). The number of co-morbidities is also linked to the 
number of medication related problems a patient is likely to experience (Manley et al. 
2003). Furthermore, patients with diabetes (who are more likely to have complex 
medicine regimens) do experience more medication related problems. The DoH has 
estimated that £5 million a day is spent by the NHS on treatment for diabetes and its 
related  complications (DoH 2003a). Additionally, the NHS has committed to 
reducing  by 40% the number of serious drug errors in the use of prescribed drugs 
(DoH 2004). Therefore reducing MEs in diabetes care for patients admitted to hospital 
is one way that significant improvement to care and sustainable savings to the NHS 
can be achieved. 
 
BACKGROUND 
There is substantial evidence to suggest that most MEs involve a chain of problems, 
and a wide variety of contributing factors that need to be considered  (Vincent 2003, 
Dean et al. 2002, Hellman 2001, Leape 1999, Reason 1990). Reason (1990), Vincent 
et al. (1998) and Dean et al. (2002) describe two types of error; slips and lapses and 
mistakes. Slips and lapses are errors of action and occur when there is a break in 
routine and attention is diverted. In comparison, mistakes, which are more difficult to 
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detect, are rule and knowledge based errors and are errors of conscious thought. They 
commonly occur from a lack of knowledge or misperception of the situation with the 
subsequent application of the wrong rule to the situation.  
 
The process of providing medications to patients is complex involving multiple sub 
processes (Clancy 2004).  Many specific factors have been associated with 
prescribing and medication errors including calculations of drug dose, errors in 
decimal points, medications with similar names, medication dosage forms, use of 
abbreviations, unusual routes of drug administration, uncommon dosage regimens, 
complicated dosage regimens, poor history taking, lack of  knowledge of the drug and 
patient, work load, and failure to follow policy and procedure (Leape et al. 1995, 
Lesar et al. 1997, O'Shea 1999, DoH 2004). In an evaluation of medication errors 
Leape et al. (1995) discovered that 39% of errors occurred during physician ordering, 
38% during administration by nurses, and the remainder were equally divided 
between pharmacy and transcription.  
 
Insulin has been identified as one of the top five medications associated  with 
medication errors that cause harm to patients (Kowiatek et al. 2001). In a recent 
initiative to reduce insulin medication errors Kowiatek et al. (2001) conducted a one 
year evaluation and review of medication errors.  The majority of errors were classed 
as wrong dose/rate, omission and incorrect drug. A more detailed analysis identified 
that prescribing and transcribing errors were also related to inappropriate use of 
abbreviations (use of word ‘unit’ vs. ‘u’ and no zeros after whole numbers), and a lack 
of instruction and training on how to write insulin orders. 
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Interventions from hospital Diabetes Specialists Nurses (DSNs) include a strong 
emphasis on patient education, support, advice, and medicines management (Cavan et 
al. 2001, Young et al. 2002, Barr-Taylor et al. 2003, Chan et al. 2006). These 
interventions have been shown to improve glycemic control and decrease LOS 
(Koproski et al. 1997, Thompson et al. 1999, Grey et al. 2002, Wong et al. 2005, 
Sampson et al. 2006).  
 
However, only minimal research has examined nurse prescribing in diabetes (James 
2004, Courtenay et al. 2007). Qualified Nurse Independent/Nurse Supplementary 
Prescribers (DoH 2003b, DoH 2006a) are able to prescribe any licensed medicine 
(and some controlled drugs) independently or, any medicine as a supplementary 
prescriber (provided that these medicines are within the prescribers area of 
competence). Supplementary prescribing takes place after an assessment and 
diagnosis of a patients condition has been made by a doctor, and a clinical 
management plan (which includes a list of medicines from which the supplementary 
prescriber is able to prescribe) has been agreed between the nurse prescriber, doctor 
and patient.  
 
Although errors are an intrinsic part of mental functioning and cannot be totally 
eliminated (Reason 1990), there is considerable evidence to suggest the fundamental 
cause usually lies in a variety of systemic features operating at the level of the task, 
the work environment, and wider organisational context  (Reason 1990, Leape 1999, 
Hellman 2001, Vincent 2003, DeLisa 2004). The primary objective  of a system 
design for safety is to make it difficult for individuals to err (Leape 1994).  Ideally a 
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system, as Leape suggests, will automatically correct errors or have mechanisms in 
place to at least detect errors in time for corrective action.  
 
It is evident that errors frequently occur in the prescription of insulin, and the 
education of healthcare professionals is a factor contributing to these errors (Kowiatek 
et al. 2001). Therefore, nurse prescribing (which provides a mechanism to educate 
and support patients and staff  (National Prescribing Centre 2005)(NPC)) creates a 
new opportunity for nurses to provide care designed to have a positive effect on the 
system for prescribing and administering insulin and or insulin and oral 
hypoglycaemic agent (OHA) medicines to patients with diabetes. 
 
THE STUDY 
Aim 
The aim of the study was to compare insulin and OHA medication errors, and LOS 
between a comparison group receiving standard inpatient care and an intervention 
group who had their medicines managed by a DSN prescriber. The specific research 
questions were: 
 
 Do patients treated by a DSN prescriber experience a reduction in the number 
of insulin and OHA medication errors? 
 Do patients treated by a DSN prescriber experience a reduction in LOS?  
 
Design  
The study was a quasi-experiment carried out using six medical (including renal) and 
surgical (including orthopaedics, vascular surgery no amputation and vascular 
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surgery) wards in a District General Hospital in the UK between May–December 
2005.  
Sample 
Subjects were a convenience sample of 56 patients with diabetes admitted onto one of 
the six wards during a three month pre-intervention phase, and three month 
intervention period with a predicted length of stay at least three days. Agreement from 
wards to participate in the study was obtained from ward managers. Seven patients in 
the pre-intervention group were readmitted twice. In the intervention group three 
patients were readmitted twice and one three times. These patients were readmitted 
for reasons other than their diabetes e.g. heart failure, renal disease and chemotherapy. 
All participants were part of a larger study, the results of which have been reported 
elsewhere (Courtenay et al. 2007).  
 
Intervention 
Within the Hospital Trust nursing and administrative staff identified  several factors 
that appeared to affect the level of care patients  in hospital with diabetes received 
(James 2003). The main areas of concern related to  delays in diabetes treatment,  
inaccuracies in prescriptions for  insulin or OHA, access to information about systems 
of delivery, gaps in knowledge about diabetes and its treatment, access to diabetes 
health professionals and lack of continuity of diabetes care. It is evident that these 
areas of concern were rooted across all parts of the medication system for patients 
with diabetes who are prescribed insulin and/ or OHA.  The medicines management 
intervention was therefore designed to address these factors.  
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During the first three months (pre-intervention phase) patient’s received standard care 
i.e.  their medicines were prescribed and managed by medical i.e. house officers, 
senior house officers and non-diabetes specialist registrars and nursing staff other than 
a DSN prescriber. Following a 1 month period designed to enable ward staff to adjust 
to a nurse-led service, data was collected for a further three months (intervention 
period). During this period, in addition to standard care, patients received care and 
advice from a DSN prescriber. This included an initial patient assessment by the DSN 
prescriber (including review of medicines regime), 1-3 individual patient education 
sessions appropriate to need (information was provided on the patients condition, 
management of medicines, any medication changes), and on-going review of patients 
medicines regime. The need for frequency and content of education sessions was 
based on the initial patient assessment.  
 
During the intervention period the DSN prescriber also provided medical and nursing 
staff with 1-2 individual education sessions appropriate to need. These sessions 
comprised information on the treatment regimes of each patient including drug action 
and dose, drug interactions and adverse effects. Nurse supplementary prescribing was 
instigated in the absence of medical staff, in an emergency, or, if a delay in 
prescribing would adversely affect the patient.  
 
Outcome measures and data collection    
The two main outcome measures were insulin and oral hypoglycaemic medication 
errors, and LOS.   
 
Medication errors 
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The findings from a preliminary audit (James 2003) undertaken within the hospital 
trust had identified a number of errors with regards to the prescribing of insulin and 
oral therapy. These errors were classifiable into 14 different categories. As part of the 
larger study (and reported elsewhere) an error chart (see Table 1), which described 
and categorised the range of possible insulin errors was developed and piloted from 
this information (Courtenay et al. 2007).  
 
During the pre-intervention and intervention phases of the study, patient’s medication 
charts (including the insulin and/or insulin infusion chart) were collected upon patient 
discharge. These charts were photocopied and made anonymous and reviewed blind 
by a researcher with a background in diabetes research. Any errors identified within 
the 14 categories were then recorded on the insulin and OHA error chart (one chart 
per person). In order to increase the robustness of this process, and as part of the 
larger study, the first 20 error charts and medication charts from which these errors 
were extracted, were reviewed by a Consultant Diabetologist (JR) (Courtenay et al. 
2007). There was agreement between the two reviewers with regards to the insulin 
errors extracted from the medication charts and recorded on the error charts. 
 
Length of Stay 
Admission and discharge dates were collected manually on all participants. Additional 
demographic information including admission category, type and management of 
diabetes, the age and sex of patient, ethnicity, employment status, accommodation, 
and history of another chronic disease or illness was also collected. LOS was 
calculated for all admissions (excluding readmissions). This information was 
collected by the DSN prescriber. 
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Data collection 
Data were collected on admission and at discharge. Admission data included 
demographic information.  Discharge data include medication errors and LOS  
 
Data analysis 
SPSS was used for data entry and analysis. Descriptive statistics were used to describe 
the demographic nature of the sample. X
2 tests were used for categorical data when 
testing for association. To ensure that cell size reached the recommended minimum of 
5 and  achieve a reasonable degree of statistical power to detect effect (Pallant 2005),  
the 14 insulin and OHA medication errors were reduced in to four  categories (Table 
2). Continuously distributed data were analysed with independent sample t-tests, and 
the Pearson-moment correlation coefficient.  
 
A general linear modelling procedure was used to explore which if any factors 
contributed significantly to explaining the variation in the total number of errors and 
LOS. These factors included age, sex, type of diabetes, time since diagnosis, 
admission category, management of diabetes, employment, accommodation, and 
having another chronic disease or illness. The model was then checked using residual 
analysis.  
 
Ethical considerations 
Approval for the study was granted by the research ethics committee of the study 
hospital and the university with which the principal investigator was affiliated. 
Agreement from wards to participate in the study was obtained from ward managers. 
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A series of staff meetings were held prior to the pre-intervention phase at which 
details (including information sheets) about the research was disseminated.  
 
RESULTS 
Fifty six patients were recruited across both the pre-intervention (n=27) and 
intervention (n=29) groups between May 2005-December 2005. Patients’ 
demographic data in the two study groups were generally similar (Table 3), although 
there is evidence that a greater proportion of patients in the pre-intervention group 
were treated with insulin and  or OHA medication, had been diagnosed with diabetes 
> 15 years and reported another chronic disease. In comparison a greater proportion of 
patients in the intervention group were admitted under medicine, and were aged less 
than 70 years. However results of chi square analysis showed that although there was 
a significant difference in the type of admission between the two groups, there were 
no significant differences in the other demographic characteristics i.e. sex, age, 
Type1/Type 2 diabetes, management of diabetes, ethnicity, employment status, 
marital status, or accommodation. 
 
Main Outcome measures 
Medication Errors 
In total medication errors were recorded for 42 patients across both the intervention 
and pre intervention groups (see Table 2). 
 
An independent samples t-test was conducted to compare the total number of errors 
between groups. There was a significant difference and reduction in the total number 
of errors between the pre-intervention group (M=26, SD=35.04) and intervention 
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group (M=5.03, SD=7.79; t(47)=2.632 p=0.016). The magnitude of the differences in 
the means was large (a mean reduction of 21 errors was identified in the intervention 
group).  
 
Some patients experienced multiple errors. The maximum number of errors recorded 
for one patient in the pre-intervention group was 130, and in the intervention group 
the maximum number of errors recorded for one patient was 33. Nurse supplementary 
prescribing was used in seven patients. 
 
Using a general linear model it was evident that admission type contributed, although 
not to a significant level (p=0.06) to the total number of errors. A greater number of 
errors were identified in patients who had been admitted to the surgical wards in both 
the pre-intervention and intervention group compared to those patients admitted to 
medicine (see Table 4). 
 
Incorrect/ unclear prescribing 
An independent samples t-test was conducted to compare the total number of 
incorrect/unclear prescribing errors between groups. There was no significant 
difference in the number of incorrect/unclear prescribing errors between the pre-
intervention group (M=6.3, SD=9.5) and intervention group (M=2.2, SD=3.8 
t(47)=1.838, p=0.08). A mean reduction of 4 errors was identified in the intervention 
group.  
 
Charts not signed/ incomplete 
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An independent samples t-test was conducted to compare the total number charts not 
signed/incomplete errors between groups. There was no significant difference in the 
number of charts not signed/incomplete errors between the pre-intervention group 
(M=3.7, SD=9.0) and intervention group (M=0.28, SD=0.7 t(47)=1.689,p=0.1). A 
mean reduction of 3.4 errors was identified in the intervention group. 
 
Dose adjustment incorrect/omitted 
An independent samples t-test was conducted to compare the total number of dose 
adjustment incorrect/omitted errors between groups. There was a significant 
difference in the total number of dose adjustment incorrect/omitted errors between the 
pre-intervention group (M=2.5, SD=4.2) and intervention group (M=0.21, SD=0.68 
t(47)=2.348, p=0.03). A mean reduction of 2.3 errors was identified in the 
intervention group. 
 
Medicines not signed as given 
An independent samples t-test was conducted to compare the total number of 
medicines not signed as given errors between groups. There was a significant 
difference and large reduction in the total number of medicines not signed as given 
errors between the pre-intervention group (M=13.55, SD=22.7) and intervention 
group (M=2.38, SD=4.92; t(47)=2.166, p=0.042). A mean reduction of 11 errors was 
identified in the intervention group.  
 
A large positive correlation was found between the number of medicines not signed as 
given and charts not signed/incomplete errors in the pre-intervention group [r=0.92, 
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n=20, p<0.001]. This effect was not present in the intervention group. A medium 
positive correlation was found between the number of medicines not signed as given 
and incorrect/unclear errors in the intervention group [r=0.44, n= 29, p<0.05]. This 
effect was not present in the pre-intervention group (see Table 5). 
 
There was no correlation between the total number of errors, the four error categories 
and length of stay, age, admission type, type and management of diabetes, ethnicity, 
employment status, accommodation, and history of another chronic disease or illness.  
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Length of Stay 
In the pre-intervention group the minimum length of stay was three days and the 
maximum 113 days, compared to a minimum of six and maximum of 52 days in the 
intervention group. Over half (54%) the patients in the pre-intervention group were in 
hospital for more than 15 days compared to 42% in the intervention group.  
 
In the pre-intervention group the median length of stay was 17.5 days (inter-quartile 
range 10.25-46.75), compared to median of 14.5 days (inter-quartile range 9.75-
32.25) in the intervention group (p<0.05). Despite this reduction in LOS, it was 
evident from the independent t-test that the difference in length of stay between the 
pre-intervention group (M=31.05, SD=31.8) and intervention group (M=21, SD= 
15.1, t(48) =1.46) was not significant (p=0.15). 
 
Using a general linear model it was evident that admission type contributed, although 
not to a significant level (p=0.42) to length of stay. Patients admitted to the surgical 
wards in the pre-intervention group experienced a mean length of stay which was 
more than double than those patients admitted under medicine (see Table 4).   In order 
to explore the extremely large difference between LOS and admission type in the pre-
intervention group, a further independent sample t-test was conducted. It was evident 
from this that admission type had a highly significant effect on LOS for this group of 
patients (p=0.0004).  
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A large, positive correlation was found to exist between the length of stay and the 
total number of errors in the pre-intervention group [r=0.5 n=18, p<0.05]. This effect 
was not present in the intervention group (See Table 5).  
 
A large positive correlation was found between medicines not signed as given errors 
and length of stay in the pre-intervention group [r=0.53, n=18, p<0.05]. This effect 
was also present in the intervention group but was less marked, [r=0.4, n=26, p<0.05] 
(See Table 5).   
 
A medium, positive correlation was found to exist between the length of stay and 
charts not signed/incomplete errors in the pre-intervention group [r=0.49 n=18, 
p<0.05]. This effect was not present in the intervention group (See Table 5).  
 
There was no correlation between length of stay and age, admission type, type and 
management of diabetes, ethnicity, employment status, accommodation, history of 
another chronic disease or illness and side effects from medicines for diabetes.  
 
DISCUSSION 
Several potential limitations of our methodology need to be taken into account. 
Firstly, only patients admitted on to one of the six wards during the three month pre-
intervention phase, and three month intervention period, were included in the study 
i.e. it was not a random sample. A second potential limitation is that only one DSN 
prescriber participated in the study. Although this helped with regards to standardising 
 19 
the patient and staff individual education sessions, there is the possibility of character 
bias.   
 
It is evident from our findings that insulin and OHA errors were recorded for nearly 
75% of patients in both the pre-intervention and intervention groups and some 
patients experienced multiple errors. The ‘medicines not signed as given’ and 
‘incorrect/unclear prescribing’  categories were the most frequent type of medication 
errors present on the medicines charts of patients  in both the pre-intervention and 
intervention groups. Our findings suggest that when the medication system failed 
multiple insulin and OHA medication errors occurred. Specifically, patients who 
experienced large numbers of ‘medicines not signed as given’ errors also experienced 
large numbers of ‘charts not signed/incomplete’ and ‘incorrect unclear’ errors. 
 
The median number of total errors in the intervention group was 1 i.e. 10 less than in 
the pre-intervention group. In addition to having a longer length of stay, this could 
have been as a result of this group of patients having a longer duration of diabetes 
requiring more complex drug regimens, and being more likely to be treated with 
insulin therapy (see Table 3). A similar percentage of patients in each group 
experienced insulin and OHA medication errors. However, it is evident from our 
findings and the substantial (72%) reduction in errors, that the medicines management 
intervention provides a system, such as that described by Leape (1994) i.e. it 
automatically corrects errors and provides a mechanism which detects errors in time 
for corrective action.  
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It is evident from our findings that the total number of insulin and OHA medication 
errors and LOS were affected by admission category. Patients admitted under surgery 
in both groups experienced a much greater number (2-4 times as many) of insulin and 
OHA medication errors than those admitted under medicine. In the pre-intervention 
group, the LOS for patients admitted under surgery was nearly three times that 
compared to those admitted under medicine.  
 
These findings suggest that the substantially higher number of insulin and OHA errors 
identified on the medicines charts of surgical patients are more likely to have occurred 
from a lack of knowledge, or misperception of the situation, with the subsequent 
application of the wrong rule to the situation as described by Vincent et al. (1998)  
and Dean et al. (2002). Furthermore, the higher number of errors had a subsequent 
detrimental effect in the pre-intervention group with regards to the LOS of patients 
admitted to these wards. It is possible, therefore that the nursing and medical staff 
working on the surgical wards may have had less experience and or confidence in 
managing the medicines of patients for their diabetes than those on medical wards, 
which ultimately affected the number of insulin and OHA medication errors their 
patients experienced.  
 
The median LOS for patients in the intervention group was 14.5 days compared to 
17.5 days for patients in the pre-intervention group. Based on a cost per patient per 
day of £250 (DoH 2006b), over one year this is a potential cost saving of £168,000. 
Although a number of factors may have affected LOS (e.g. severity of illness, 
availability of investigations, and response to treatment) a correlation was found to 
exist, in the pre-intervention group, between LOS and the total number of errors and 
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also between LOS and the error category ‘medicines not signed as given’ i.e. as the 
total number of errors increased, so did LOS.  
 
These findings are in-line with those reported by previous research (Wilson et al. 
1995, Classen et al. 1997, Vincent et al. 2001). Wilson et al. (1995) in a retrospective 
review of  14,000 medical  records of patients in Australia reported that adverse 
events accounted for an additional seven hospital bed days per admission, of which 
51% were highly preventability. Additionally, cognitive error (including both slips 
and lapses and mistakes) was deemed to play a part in nearly 60% of these adverse 
events. More recently in the UK, Vincent et al. (2001), conducted a retrospective 
review of 1014 patients records and similarly reported that 50% of adverse events are 
preventable. Similar findings were reported within the Hospital Trust by James (2003) 
in a review of hospital patients with poorly controlled diabetes. In this small scale 
study it was identified that over 50% of the medication errors for the management of 
diabetes were preventable.  
 
Although not looking at nurse prescribing, a reduction in LOS when care has been 
provided by DSN has been reported by a number of researchers (Davies et al. 2001, 
Cavan et al. 2001, Koproski et al. 1997, Sampson et al. 2006, Courtenay et al. 2007) .  
Sampson et al. (2006), for example in a study of 14, 722 patients with diabetes, 
reported  the mean excess bed days was significantly lower in patients who received 
individual structured information  and  practical management of diabetes from a DSN, 
compared to those patients who had not.  
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In line with these findings, and as part our larger study, a reduction in insulin and 
OHA medication errors was identified in a sample of 452 patients whose medicines 
were managed by a DSN prescriber (Courtenay  et al. 2007). Furthermore the median 
length of stay was significantly lower in patients who had received the medicines 
management intervention compared to those who had not. 
 
Our findings are in line with policy and the literature  (Leape 1994, Hellman 2001, 
DoH 2003a, Woloshynowych et al. 2005, Clinical Resource Efficiency Support Team 
(CREST) 2006). The National Service Framework (NSF) for Diabetes emphasises the 
role of the nurse in the care of patients with diabetes (DoH 2003a). More recently, 
recommendations for the safe and effective use of insulin in secondary care (CREST 
2006) also emphasize the role of the DSN, the importance of education and training, 
and the use of audit in improving standards of care for in-patients with diabetes. New 
methods and improved ways of working are therefore essential if the process of 
prescribing and administering of medicines to patients with diabetes is to be improved 
(Leape 1994, Hellman 2001). However, more attention as Woolshynowych  et al. 
(2005) suggest must be given to psychological and human factors that contribute to 
error, particularly the fact that liability to error is strongly affected by the context and 
conditions of work.  It is evident that the medicines management intervention 
delivered by a DSN prescriber had a dramatic effect on both the medication system 
and the number of insulin and OHA medication errors patients experienced.   
 
CONCLUSION 
In most high-risk industries, learning from accidents or near misses is a long 
established practice and a cornerstone of safety analysis and improvement. There is 
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substantial evidence to suggest that most incidents involve a chain of problems, and a 
wide variety of contributing factors that need to be considered. We have shown that 
the medicines management intervention delivered by a DSN prescriber has a positive 
effect on the system of delivering medicines to patients with diabetes, and 
substantially reduced the number of insulin and OHA medication errors. This 
reduction had some effect on LOS. The reduced LOS of patients in the intervention 
group produced a cost saving sufficient to fund at least the cost of a DSN prescriber 
post. 
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Table 1: Insulin and OHA medication errors  
 
 
 
 
 
 
 
 
 
 
 
Insulin doses not signed as given 
Name of insulin incorrect 
Insulin/Oral medication dose not adjusted when persistent BG>14mmols 
Insulin/Oral medication dose not adjusted with persistent BG <4mmol 
Insulin chart not signed by prescriber  
Inappropriate dose of short acting insulin 
 administered in response to hyperglycaemia 
Unit  Abbreviated  to ‘u’ and unclear  
Insulin not written up 
Oral hypoglycaemic agents not signed as given 
Number of units of dose unclear 
Sliding scale doses not signed as given.  
State number of doses 
Omission of Insulin after hypoglycemia 
Prescription chart not signed by prescriber 
Chart Incomplete 
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Table2: Insulin and OHA Medication Errors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Error category Pre-Intervention Intervention Difference 
Incorrect/Unclear prescribing including: name 
of insulin incorrect, number of units of dose 
unclear, unit abbreviated to ‘u’ and unclear,  
insulin not written up 
126 63 -63 
Medicines not signed as given including: 
OHA not signed as given, insulin doses not 
signed as given, sliding scale not signed as given 
271 69 -202 
Charts not signed/incomplete including: 
Insulin chart not signed by prescriber, 
prescription chart not signed by prescriber, charts 
incomplete 
74 8 -66 
Dose adjustment incorrect/omitted including 
Insulin/oral medication dose not adjusted with 
BG<4mmol, or BG>14mmol inappropriate dose 
of short acting insulin in response to 
hypoglycaemia 
49 6 -43 
Sum of Total Errors 520 146 -374 (-72%) 
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Table 3: Comparison of patient characteristics in the two study groups 
 
            X
2 test Pre Intervention 
(n=27) 
Intervention 
(n=29) 
P value 
Type of Diabetes n            % n                % P=1.00 
Type 1 5 18.5% 5 17.2%  
Type 2 19 70.4% 23 79.2%  
Sex   P=0.836 
Male 16 59.3% 19 65.5%  
Female 11 40.7% 10 34.5%  
Management of Diabetes   P=0.206 
Oral Hypoglycaemic Agents 10 37% 10 34.5%  
Insulin with OHA and Insulin only 14 51.9% 15 51.7%  
Diet only 0 0% 3 10.3%  
Type of Admission    P=0.02 
Medicine (including renal) 9 33.3% 19 65.5%  
Surgery (including orthopaedics, 
vascular surgery, vascular 
amputation) 
17 63.7% 8 27.6%  
Age     P=0.254 
<50 years 3 11.1% 6 20.7%  
51-69 years 11 40.7% 15 51.7%  
> 70 years 13 48% 8 27.6%  
Marital status     P=1.00 
Married/living together 12 44.4% 13 44.8%  
Divorced/separate/single/widowed 15 55.6% 16 55.2%  
Employment     P=0.883 
Not employed 20 74.1% 23 79%  
Employed 7 25.9% 6 20.7%  
Ethnicity     P=0.587 
White 25 92.6% 28 96.6%  
Asian/Black/ British Asian/British 
Black 
2 7.4% 1 3.4%  
How long since diagnosed?     P=0.300 
0-15 years 15 55.6% 21 72.4%  
> 15 years 12 44.4% 8 27.6%  
Other chronic disease/illness     P= 0.589 
No 10 37% 5 17.2%  
Accommodation      P=0.217 
Detached or semi detached house 23 85.2% 20 71.4%  
Terrace or flat 4 14.8% 8 28.6%  
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Table 4: Effect of Admission Category and Group on Insulin and OHA 
medication errors and LOS 
 
 
  Pre Intervention Intervention 
 Adjusted mean number of total errors   
Surgery  35 8 
Medicine  9 4 
       Significance Probability= 0.06 
 Adjusted mean length of stay   
Surgery  41 22 
Medicine  15 21 
  Significance Probability= 0.41 
 
(The means are adjusted to take account of the other factors included in the model)
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Table 5: Significant correlations and relationships 
 
 
 
 
 
 
 
 
Measures  Pre-Intervention Intervention 
  r n P = r  n P = 
Length of stay Medicines not 
signed as given 
0.53 18 0.024 0.4 26 0.045 
 Total Errors 0.5 18 0.036    
 Charts not signed  
/incomplete 
0.49 18 0.040    
Total Errors Medicines not 
signed as given 
0.96 20 0.00 0.87 29 0.00 
 Charts not signed 
/incomplete 
0.88 20 0.00 0.4 29 0.033 
 Incorrect/ 
Unclear prescribing 
0.47 20 0.036    
Medicines not signed 
 as given 
Charts not signed 
/incomplete 
0.92 20 0.000    
 Incorrect/ 
Unclear prescribing 
   0.44 29 0.017 
